Dear Reader, Frankly, I'm puzzled…
I honestly can't figure out why you haven't yet registered for tonight's live presentation.
For one thing, tonight's event could help you learn how to start collecting cash payouts of $535... $623... even $1,207 or more... All with just a few clicks of your mouse... in 5 minutes or less. (We'll prove to you it's possible, tonight.)
For another thing, it's free to watch... And, you'll get to learn Dr. David Eifrig's low-risk options trading method, which he perfected after ten years of trading on Wall Street. (In the past, his Wall Street clients have paid thousands of dollars for this sort of information.) And on top of THAT... "Doc" is going to walk a 28-year-old newbie through her very first trade using his simple technique. You'll be able to see the whole thing, from top to bottom, in her actual brokerage account. If you haven't registered yet… I can only assume it's because you're not interested in learning how to potentially add thousands of dollars per month to your retirement account...
Or perhaps you have plans you simply can't reschedule…
Either way, I think you're making a HUGE mistake if you don't sign up for tonight's event at 8 PM Eastern right now.
Again, the event is absolutely free to attend, so you have nothing to lose.
But the reality is, if you don't attend, you will miss out on learning Dr. Eifrig's special trading technique for free... Bottom-line: you simply can't afford to miss Doc's first-ever LIVE demonstration of his conservative strategy. As Doc puts it, "This is one of the simplest, safest, and most consistent sources of income the market has to offer today. You're leaving money on the table if you're not using it!"
Even if you don't plan to use this method for yourself, you should AT LEAST learn the truth about options from a former Wall Street trader... and how to use them to generate instant cash payouts...
So I urge you, take a minute to pre-register now… and tune in tonight at 8 PM, Eastern.
See you tonight,
Mike Cottet
Director of Member Services
Stansberry Research | 